Pedro Luis Sánchez Fernández-rekin lankidetzan egindako argitalpenak (6)

2022

  1. Clinical and economic impact of cardiac magnetic resonance-guided decision-making

    Revista Espanola de Cardiologia, Vol. 75, Núm. 7, pp. 610-612

  2. Incidencia, morbimortalidad y tratamiento del síndrome coronario agudo durante el confinamiento por COVID-19

    REC: Interventional Cardiology, Vol. 4, Núm. 3, pp. 186-192

  3. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2018

  1. No differences in levels of circulating progenitor endothelial cells or circulating endothelial cells among patients treated with ticagrelor compared with clopidogrel during non–ST-segment–elevation myocardial infarction

    Journal of the American Heart Association, Vol. 7, Núm. 19

2015

  1. Comparison of different bone marrow-derived stem cell approaches in reperfused STEMI: A multicenter, prospective, randomized, open-labeled TECAM trial

    Journal of the American College of Cardiology, Vol. 65, Núm. 22, pp. 2372-2382

2007

  1. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: The GRACIA-2 non-inferiority, randomized, controlled trial

    European Heart Journal, Vol. 28, Núm. 8, pp. 949-960